Dr. Sharmila Roy Chowdhury

Get to Know Dr. Sharmila Roy Chowdhury

Surgical oncologist Dr. Sharmila Roy Chowdhury specializes in the use of novel hyperthermic intraperitoneal chemotherapy, known as HIPEC, which has dramatically improved treatment for peritoneal mesothelioma cancer.

Chowdhury uses HIPEC in combination with cytoreductive surgery in treating several different abdominal malignancies.

Her practice at Southwest Cancer Surgery in Plano, Texas, focuses on gastrointestinal oncology and rare cancers such as pseudomyxoma peritonei, appendix cancer and mesothelioma. She also treats peritoneal carcinomatosis, stomach cancer and liver cancer.

While many doctors, and even oncologists, struggle with properly identifying peritoneal mesothelioma, Chowdhury has extensive experience with mesothelioma treatment.

Chowdhury is the former director of the Peritoneal Surface Malignancy and HIPEC Program at Medical City Plano, and started similar programs at Indiana University Hospital and Loma Linda University Medical Center in California.

Specialties of Dr. Sharmila Roy Chowdhury

• Peritoneal mesothelioma
• Gastrointestinal oncology
• Peritoneal carcinomatosis
• Cytoreductive surgery
• HIPEC

Dr. Sharmila Roy Chowdhury’s Experience and Education

• Southwest Cancer Surgery
• Medical City Plano
• Indiana University Hospital
• Loma Linda University Medical Center
• University of Pittsburgh Medical Center (Fellowship)
• Seth G.S. Medical College and K.E.M. Hospitals (Residency)
• Providence Hospital and Medical Centers (Residency)
• Staten Island University Hospital (Residency)
• Rutgers New Jersey Medical School (Residency)
• Jawaharlal Institute of Postgraduate Medical Education and Research (M.D.)

Awards and Certifications

• Society of Surgical Oncology Accredited Fellowship
• Trustees’ Teaching Award, Indiana University School of Medicine (2015)
• ASCO Merit Award (2005)
• Board certified in surgery

Publications of Dr. Sharmila Roy Chowdhury

• Roos, M. et al. (2010, October). The impact of multidisciplinary therapy in node-positive rectal cancer. American Journal of Surgery.
• Kuo, J. et al. (2010, October). The use of pelvic radiation in stage II rectal cancer: a population based analysis. American Journal of Surgery.
• Olaya, W. et al. (2009, October). Disparities in the surgical management of women with stage I breast cancer. American Journal of Surgery.